| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/32861334_HAS_TOPIC_C0004376> <https://research.tib.eu/covid-19/entity/32861334_HAS_TOPIC_C0009449> <https://research.tib.eu/covid-19/entity/32861334_HAS_TOPIC_C0009607> <https://research.tib.eu/covid-19/entity/32861334_HAS_TOPIC_C0026350> <https://research.tib.eu/covid-19/entity/32861334_HAS_TOPIC_C0030494> <https://research.tib.eu/covid-19/entity/32861334_HAS_TOPIC_C0032310> <https://research.tib.eu/covid-19/entity/32861334_HAS_TOPIC_C0037421> <https://research.tib.eu/covid-19/entity/32861334_HAS_TOPIC_C0037585> <https://research.tib.eu/covid-19/entity/32861334_HAS_TOPIC_C0037588> <https://research.tib.eu/covid-19/entity/32861334_HAS_TOPIC_C0037589> <https://research.tib.eu/covid-19/entity/32861334_HAS_TOPIC_C0039778> <https://research.tib.eu/covid-19/entity/32861334_HAS_TOPIC_C0079161> <https://research.tib.eu/covid-19/entity/32861334_HAS_TOPIC_C0079990> <https://research.tib.eu/covid-19/entity/32861334_HAS_TOPIC_C0086272> <https://research.tib.eu/covid-19/entity/32861334_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/32861334_HAS_TOPIC_C0206750> <https://research.tib.eu/covid-19/entity/32861334_HAS_TOPIC_C0876936> <https://research.tib.eu/covid-19/entity/32861334_HAS_TOPIC_C1615608> <https://research.tib.eu/covid-19/entity/32861334_HAS_TOPIC_C3658303> <https://research.tib.eu/covid-19/entity/32861334_HAS_TOPIC_C3694279> <https://research.tib.eu/covid-19/entity/32861334_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/32861334_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/32861334_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/32861334_HAS_TOPIC_C5392173> <https://research.tib.eu/covid-19/entity/32861334_HAS_TOPIC_C5392189> <https://research.tib.eu/covid-19/entity/32861334_HAS_TOPIC_C5392190> <https://research.tib.eu/covid-19/entity/32861334_HAS_TOPIC_C5392950> <https://research.tib.eu/covid-19/entity/32861334_HAS_TOPIC_C5392970>
?:authorAffiliation	[\'GlaxoSmithKline US, Collegeville, PA. Electronic address: andrea.8.nuzzo@gsk.com.\', \'Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital, Boston, MA; Neuroradiology, Department of Radiology, Massachusetts General Hospital, Boston, MA.\', \'Media Lab, Massachusetts Institute of Technology, Boston, MA.\', \'Division of Infectious Disease, Mayo Clinic, Rochester, MN; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.\', \'Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.\', \'Neuroradiology, Department of Radiology, Massachusetts General Hospital, Boston, MA.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/DeSimone_Daniel_C> <https://research.tib.eu/covid-19/entity/Gupta_Rajiv> <https://research.tib.eu/covid-19/entity/Kapa_Suraj> <https://research.tib.eu/covid-19/entity/Nuzzo_Andrea> <https://research.tib.eu/covid-19/entity/Raskar_Ramesh> <https://research.tib.eu/covid-19/entity/Tan_Can_Ozan>
?:doi	<https://research.tib.eu/covid-19/entity/S0025-6196%2820%2930649-210.1016/j.mayocp.2020.06.027>
?:doi	S0025-6196(20)30649-210.1016/j.mayocp.2020.06.027
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Mayo Clinic proceedings
is ?:pmid of	<https://research.tib.eu/covid-19/entity/32861334>
?:pmid	<https://research.tib.eu/covid-19/entity/32861334>
?:pmid	32861334
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	2.551
?:rankingScore_hIndex	153
?:title	Universal Shelter-in-Place Versus Advanced Automated Contact Tracing and Targeted Isolation: A Case for 21st-Century Technologies for SARS-CoV-2 and Future Pandemics.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2020

Property

Value

is ?:annotates of

?:authorAffiliation

[\'GlaxoSmithKline US, Collegeville, PA. Electronic address: andrea.8.nuzzo@gsk.com.\', \'Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital, Boston, MA; Neuroradiology, Department of Radiology, Massachusetts General Hospital, Boston, MA.\', \'Media Lab, Massachusetts Institute of Technology, Boston, MA.\', \'Division of Infectious Disease, Mayo Clinic, Rochester, MN; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.\', \'Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.\', \'Neuroradiology, Department of Radiology, Massachusetts General Hospital, Boston, MA.\']

?:citedBy

-1

?:creator

?:doi

<https://research.tib.eu/covid-19/entity/S0025-6196%2820%2930649-210.1016/j.mayocp.2020.06.027>

?:doi

S0025-6196(20)30649-210.1016/j.mayocp.2020.06.027

?:hasPublicationType

<https://research.tib.eu/covid-19/entity/Journal_Article>

?:journal

Mayo Clinic proceedings

is ?:pmid of

<https://research.tib.eu/covid-19/entity/32861334>

?:pmid

<https://research.tib.eu/covid-19/entity/32861334>

?:pmid

32861334

?:publication_isRelatedTo_Disease

<https://research.tib.eu/covid-19/entity/Covid-19>

?:rankingScore_SJR

2.551

?:rankingScore_hIndex

?:title

Universal Shelter-in-Place Versus Advanced Automated Contact Tracing and Targeted Isolation: A Case for 21st-Century Technologies for SARS-CoV-2 and Future Pandemics.

?:type

?:year

2020

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/32861334>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/32861334>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

Metadata